Biotech Breakthroughs
Invest in

Biotech Breakthroughs

32.4%
2.6%
0.1%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See more
32.4%
2.6%
0.1%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Biotech Breakthroughs Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
27.0% Cancer 28.7%
14.7% Amgen Inc AMGN 30.5%
9.1% Celgene Corp. CELG 31.3%
1.2% Seattle Genetics Inc. SGEN 24.0%
1.1% Spectrum Pharmaceuticals Inc. SPPI 21.0%
0.8% Medivation Inc. MDVN 43.9%
22.4% Autoimmune Disorders 58.7%
12.3% Biogen Inc BIIB 22.5%
5.6% BioMarin Pharmaceutical Inc. BMRN 112.7%
1.9% Incyte Corp. INCY 87.3%
1.5% Xencor Inc XNCR 105.4%
1.1% ACADIA Pharmaceuticals Inc. ACAD 77.4%
19.0% Infectious Diseases 41.3%
15.3% Gilead Sciences Inc. GILD 33.7%
2.6% Opko Health Inc. OPK 85.5%
1.0% Emergent Biosolutions Inc. EBS 41.0%
17.8% Other Diseases 34.8%
4.8% Alexion Pharmaceuticals Inc. ALXN 12.0%
4.8% Regeneron Pharmaceuticals Inc. REGN 64.2%
3.7% Vertex Pharmaceuticals Incorporated VRTX 28.7%
1.5% United Therapeutics Corporation UTHR 89.2%
1.1% The Medicines Company MDCO 4.4%
1.0% Alkermes plc ALKS 25.7%
0.9% Acorda Therapeutics Inc. ACOR 5.7%
13.9% Research & Diagnostics 18.7%
4.4% Illumina Inc. ILMN 22.3%
4.1% Quintiles Transnational Holdings Q 34.1%
3.0% Qiagen N.V. QGEN 2.9%
1.6% Bio-Techne Corp TECH --
0.8% Abaxis Inc. ABAX 15.6%